Pxevi
FASTA
Metadata
Reference
Data
| identifier | Pxevi |
|---|---|
| alternative_identifiers | - |
| country | Spain |
| continent | Europe |
| region | Iberia |
| culture | Iberia_CA |
| epoch | Copper Age |
| group | CAIB |
| comment | - |
| latitude | 42.46523666381836 |
| longitude | -7.035059928894043 |
| sex | U |
| site | Pala da vella, Rubia, Ourense |
| site_detail | - |
| mt_hg | J2a1 |
| ychr_hg | - |
| year_from | -3354 |
| year_to | -3090 |
| date_detail | 5304-5040 calBP |
| bp | 4500±35 |
| c14_lab_code | GrN-19395 |
| c14_sample_tag | True |
| c14_layer_tag | - |
| avg_coverage | 167.8000030517578 |
| sequence_source | fasta |
| reference | Gonzalez-Fortes et al. 2019. A western route of prehistoric human migration from Africa into the Iberian Peninsula. Proceedings of the Royal Society B: Biological Sciences, 286(1895), 20182288. (link) |
| data_link | https://www.ncbi.nlm.nih.gov/nuccore/MK321344.1 |
| ychr_snps | - |
| mitopathos | [{'allele': '11251G', 'position': 11251, 'status': 'Reported', 'homoplasmy': 'nr', 'heteroplasmy': 'nr', 'locus': ['MT-ND4'], 'diseases': ['Reduced risk of PD']}, {'allele': '11253C', 'position': 11253, 'status': 'Reported', 'homoplasmy': '+', 'heteroplasmy': '-', 'locus': ['MT-ND4'], 'diseases': ['LHON PD']}, {'allele': '10398G', 'position': 10398, 'status': 'Reported / lineage L & M marker / also hg IJK', 'homoplasmy': '+', 'heteroplasmy': '-', 'locus': ['MT-ND3'], 'diseases': ['PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy']}, {'allele': '13708A', 'position': 13708, 'status': 'Conflicting reports', 'homoplasmy': '+', 'heteroplasmy': '+', 'locus': ['MT-ND5'], 'diseases': ['LHON / Increased MS risk / higher freq in PD-ADS']}, {'allele': '150T', 'position': 150, 'status': 'Conflicting reports', 'homoplasmy': '+', 'heteroplasmy': '+', 'locus': ['MT-CR'], 'diseases': ['Longevity / Cervical Carcinoma / HPV infection risk']}, {'allele': '15257A', 'position': 15257, 'status': 'Conflicting reports', 'homoplasmy': '+', 'heteroplasmy': '-', 'locus': ['MT-CYB'], 'diseases': ['LHON']}, {'allele': '195C', 'position': 195, 'status': 'Reported', 'homoplasmy': '+', 'heteroplasmy': '+', 'locus': ['MT-CR'], 'diseases': ['BD-associated / melanoma pts']}, {'allele': '295T', 'position': 295, 'status': 'Reported', 'homoplasmy': '+', 'heteroplasmy': '-', 'locus': ['MT-CR'], 'diseases': ['Low VO2max response']}, {'allele': '4216C', 'position': 4216, 'status': 'Conflicting reports', 'homoplasmy': '+', 'heteroplasmy': '-', 'locus': ['MT-ND1'], 'diseases': ['LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage']}, {'allele': '489C', 'position': 489, 'status': 'Reported', 'homoplasmy': '+', 'heteroplasmy': '-', 'locus': ['MT-CR'], 'diseases': ['Low VO2max response']}] |
Pxevi
